PREFERENTIAL GENERATION OF IPSC CARRYING ANTIGEN SPECIFIC TCRS FROM TUMOR INFILTRATING LYMPHOCYTES
Disclosed are methods for reprogramming cancer-reactive T cells into iPSC cells as well as methods utilizing such cells for the identification of cancer-antigen specific TCRs and the treatment of cancer.
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
28.06.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Disclosed are methods for reprogramming cancer-reactive T cells into iPSC cells as well as methods utilizing such cells for the identification of cancer-antigen specific TCRs and the treatment of cancer. |
---|---|
Bibliography: | Application Number: EP20210769306 |